Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance.

Autor:	Hirpara J; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Thuya WL; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Cheow SH; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Fernando K; Departmental of Biomedical Engineering, National University of Singapore, Singapore., Eu JQ; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Wang L; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Pharmacology, National University of Singapore, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Wong AL; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore., Fong ELS; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Departmental of Biomedical Engineering, National University of Singapore, Singapore.; The N. 1 Institute of Health, National University of Singapore., Ali AB; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Ding LW; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Zhuoran W; Departmental of Biomedical Engineering, National University of Singapore, Singapore., Lim YC; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Pervaiz S; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Goh BC; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Pharmacology, National University of Singapore, Singapore.; NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore.
Jazyk:	angličtina
Zdroj:	Theranostics [Theranostics] 2024 Sep 30; Vol. 14 (16), pp. 6350-6369. Date of Electronic Publication: 2024 Sep 30 (Print Publication: 2024).
DOI:	10.7150/thno.100374
Abstrakt:	Rationale: Growing evidence points to the tumor microenvironment's role in developing drug resistance. A key element of this microenvironment is inter-cellular communication, which includes the release of membrane-encapsulated vesicles containing various cargo, known as extracellular vesicles (EVs). Understanding how EVs contribute to acquired resistance holds significant clinical implications. Methods: Differential centrifugation-based methods were used to isolate EVs from established cell lines and human plasma. TMT labeling proteomics analysis of EVs revealed an abundance of metabolic transporter proteins. Increased expression of SLC1A5 in EVs of patient-derived plasma and cell lines rendered resistant to tyrosine kinase inhibitors and its relationship with progression-free survival was assessed using Kaplan-Meier survival plot. Gene knockdown and overexpression of SLC1A5 were used to validate its effect on Tyrosine kinase inhibitor (TKI) resistance. Co-culture assays using inserts was used to evaluate the effect of resistant EVs on normal fibroblasts and epithelial cells. Next, mouse-derived tumor slices (MDTS) were cultured in vitro to assess the effect of resistant EVs. Results: We report here that TKI-sensitive cells are rendered resistant upon incubation with EVs derived from TKI-resistant cell lines. Metabolic transporters, in particular SLC1A5 and SLC25A5, are upregulated in EVs derived from TKI-resistant cells and plasma from patients harbouring TKI-resistant tumors and in TKI-resistant cell lines. Furthermore, we also provide evidence for the increased abundance of pSTAT3 and the stemness marker ALDH1A1 upon EV-induced resistance. Notably, resistant EVs trigger phenotypic and functional switching of lung-derived fibroblasts into tumor-associated fibroblasts, significantly increasing their migratory and invasive capacities. Conclusions: Our findings support the role of metabolic transporters within tumor-derived EVs in reshaping the tumor microenvironment to promote therapy resistance, which could have potential diagnostic, prognostic, and therapeutic implications. Competing Interests: Competing Interests: The authors have declared that no competing interest exists. (© The author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu